Which testosterone measurement is typically used to diagnose hypogonadism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Which Testosterone Measurement is Used to Diagnose Hypogonadism

Total testosterone measured on two separate mornings is the primary test used to diagnose hypogonadism, with a threshold below 300 ng/dL supporting the diagnosis. 1

Primary Diagnostic Test

  • Morning total testosterone is the initial and primary measurement, obtained between 8-10 AM in a fasting state 1, 2
  • Two separate measurements are mandatory to confirm the diagnosis, as testosterone levels fluctuate and assay variability exists 1, 3
  • The diagnostic threshold is <300 ng/dL (some guidelines use 275-350 ng/dL range), measured using an accurate assay method 1, 2
  • Liquid chromatography-tandem mass spectrometry performed in a CDC-certified laboratory (HoST Program) provides the most accurate measurement 3

When to Add Free Testosterone Measurement

Free testosterone becomes essential in specific clinical scenarios where total testosterone alone is unreliable:

  • Men with borderline total testosterone in the "grey zone" of 230-350 ng/dL (8-12 nmol/L) 2
  • Obese patients where altered SHBG levels may cause misleadingly low total testosterone 2, 4
  • Conditions that alter SHBG including aging, liver disease, thyroid disorders, and certain medications 2, 5
  • Free testosterone should be measured by equilibrium dialysis, which is the gold standard method 2, 3, 5
  • Alternatively, calculate the free testosterone index (total testosterone/SHBG ratio), with values <0.3 indicating hypogonadism 2

Additional Required Measurements

Once low testosterone is confirmed, measure LH and FSH to distinguish primary (testicular) from secondary (hypothalamic-pituitary) hypogonadism, as this distinction has critical treatment implications including fertility preservation 2, 5

  • Elevated LH/FSH with low testosterone = primary hypogonadism 2
  • Low or low-normal LH/FSH with low testosterone = secondary hypogonadism 2

Critical Diagnostic Requirements

The diagnosis requires BOTH biochemical confirmation AND clinical symptoms/signs - testosterone levels alone are insufficient 1, 2:

  • Reduced libido, erectile dysfunction, diminished energy, reduced endurance, fatigue, depression, poor concentration, or infertility 1
  • Physical examination findings including reduced body hair, gynecomastia, small testes, or increased body fat 1

Common Pitfalls to Avoid

  • Never diagnose based on a single measurement - diurnal variation and assay variability mandate confirmation 1, 3
  • Never measure testosterone in the afternoon or evening when levels are physiologically lower 1, 2
  • Never use screening questionnaires alone to diagnose hypogonadism, as they lack specificity 1, 2
  • Never diagnose hypogonadism in men currently on testosterone therapy - exogenous testosterone suppresses the HPT axis and invalidates diagnostic testing 2
  • In obese men with proportionately reduced testosterone and SHBG but normal LH/FSH, this represents pseudo-hypogonadism of obesity, not pathological hypogonadism requiring testosterone therapy 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnosing Hypogonadism with Testosterone Labs

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Accurate Measurement and Harmonized Reference Ranges for Total and Free Testosterone Levels.

Endocrinology and metabolism clinics of North America, 2022

Research

Approach to the patient: Low testosterone concentrations in men with obesity.

The Journal of clinical endocrinology and metabolism, 2025

Research

Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.

The Journal of clinical endocrinology and metabolism, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.